AEPCX | RIVJX | AEPCX / RIVJX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 5 years | - |
Gain YTD | 6.542 | 7.626 | 86% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131B | 2.1B | 6,235% |
Annual Yield % from dividends | 0.81 | 1.36 | 60% |
Returns for 1 year | 0.68 | 5.78 | 12% |
Returns for 3 years | -0.13 | 15.89 | -1% |
Returns for 5 years | 4.58 | 27.14 | 17% |
Returns for 10 years | 16.25 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWVX | 72.83 | 1.47 | +2.06% |
Rydex Emerging Markets 2X Strategy H | |||
JFNSX | 67.87 | -0.48 | -0.70% |
Janus Henderson Global Life Sciences S | |||
VAGVX | 27.26 | -0.25 | -0.91% |
Vanguard Advice Select Global Value Adml | |||
NQGAX | 36.33 | -0.37 | -1.01% |
Nuveen Global Equity Income A | |||
GSLIX | 16.61 | -0.25 | -1.48% |
Goldman Sachs Large Cap Value Instl |